Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria

B.B. Ma; A.D. King; L. Leung; A. Poon; K. Wang; H. Loong; R. Ho; F. Mo; W.M. Ho; C. Chan; A.T. Chan; Sze Chuen Cesar Wong

Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria

B.B. Ma, A.D. King, L. Leung, A. Poon, K. Wang, H. Loong, R. Ho, F. Mo, W.M. Ho, C. Chan, A.T. Chan, Sze Chuen Cesar Wong

Research output: Unpublished conference presentation (presented paper, abstract, poster) › Conference presentation (not published in journal/proceeding/book) › Academic research › peer-review

Original language	English
Publication status	Published - 2014
Event	American Society of Clinical Oncology. Meeting - Duration: 1 Jan 2014 → …

Conference

Conference	American Society of Clinical Oncology. Meeting
Period	1/01/14 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Ma, B. B., King, A. D., Leung, L., Poon, A., Wang, K., Loong, H., Ho, R., Mo, F., Ho, W. M., Chan, C., Chan, A. T., & Wong, S. C. C. (2014). Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria. Paper presented at American Society of Clinical Oncology. Meeting.

@conference{e629766c22114a14a12f8944e9a6a081,

title = "Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria",

author = "B.B. Ma and A.D. King and L. Leung and A. Poon and K. Wang and H. Loong and R. Ho and F. Mo and W.M. Ho and C. Chan and A.T. Chan and Wong, {Sze Chuen Cesar}",

year = "2014",

language = "English",

note = "American Society of Clinical Oncology. Meeting ; Conference date: 01-01-2014",

}

Ma, BB, King, AD, Leung, L, Poon, A, Wang, K, Loong, H, Ho, R, Mo, F, Ho, WM, Chan, C, Chan, AT & Wong, SCC 2014, 'Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria', Paper presented at American Society of Clinical Oncology. Meeting, 1/01/14.

Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria. / Ma, B.B.; King, A.D.; Leung, L. et al.
2014. Paper presented at American Society of Clinical Oncology. Meeting.

Research output: Unpublished conference presentation (presented paper, abstract, poster) › Conference presentation (not published in journal/proceeding/book) › Academic research › peer-review

TY - CONF

T1 - Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria

AU - Ma, B.B.

AU - King, A.D.

AU - Leung, L.

AU - Poon, A.

AU - Wang, K.

AU - Loong, H.

AU - Ho, R.

AU - Mo, F.

AU - Ho, W.M.

AU - Chan, C.

AU - Chan, A.T.

AU - Wong, Sze Chuen Cesar

PY - 2014

Y1 - 2014

M3 - Conference presentation (not published in journal/proceeding/book)

T2 - American Society of Clinical Oncology. Meeting

Y2 - 1 January 2014

ER -

Ma BB, King AD, Leung L, Poon A, Wang K, Loong H et al.. Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC) - a prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomorgraphy (PET) and the RECIST criteria. 2014. Paper presented at American Society of Clinical Oncology. Meeting.